FR941004-2-00098 FR941004-2-00063 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary [GN # 2275] Notice of Three Meetings of the Commission on Research Integrity Pursuant to P.L. 92&hyph;463, notice is hereby given of three future meetings of the Commission on Research Integrity. Meetings are subject to availability of funds and interested parties are advised to call the Executive Secretary shortly before scheduled meetings to verify each date and place. The meetings are planned as follows: •Wednesday, October 19th, from 9 a.m. to 5 p.m. at the Stouffer Concourse Hotel, James Room, 2399 Jefferson Davis Highway, Arlington, VA 22202. The Commission invites respondents in alleged misconduct cases and attorneys who have advised them to present their views in person or in writing on the strengths and weaknesses of the way institutions and the Public Health Service (PHS) pursue such allegations. The Commission will also continue to discuss definitions of research misconduct. •Monday, November 7th, from 8:30 a.m. to 4:30 p.m. at the National Institutes of Health, 9500 Rockville Pike, Building 31, Conference Room 6, Bethesda, MD 20892. The Commission is planning a dialogue with the Director, NIH, and other intramural and extramural officials and employees on the strengths and weaknesses of the present PHS system of pursuing scientific misconduct. •Thursday, December 1st, from 9 a.m. to 5 p.m. and on Friday, December 2nd, from 8 a.m. to 3 p.m. at the Stouffer Concourse Hotel, Potomac Room, 2399 Jefferson Davis Highway, Arlington, VA 22202. On the first day, the Commission invites whistleblowers and witnesses in alleged scientific misconduct cases and counsel who have advised them to present their views in person or in writing on the strengths and weaknesses of the way the PHS and institutions pursue such allegations. On the second day, the Commission will continue its discussion of specific issues in scientific misconduct and the responsible conduct of research. The mandate of the Commission is to develop recommendations for the Secretary of Health and Human Services and the Congress on the administration of Section 493 of the PHS Act, as amended by and added to, by Section 161 of the NIH Revitalization Act of 1993. Discussion items may include but will not be limited to the issues noted above. Henrietta D. Hyatt-Knorr, Executive Secretary, Commission on Research Integrity, at the Office of Research Integrity, Division of Policy and Education, Rockwall II, Suite 700, 5515 Security Lane, Rockville MD 20852, (301) 443&hyph;5300, will furnish meeting agendas, the Committee charter, and a roster of the Committee members upon request. Persons wishing to make presentations should contact the Executive Secretary. Depending on the number of oral presentations and other considerations, the Executive Secretary will allocate a reasonable timeframe for each speaker. Commission members will prepare questions to guide witnesses in their presentations. The questions should be obtained from the Executive Secretary. More detailed statements from witnesses on their individual experiences may be submitted in writing to the Executive Secretary before or at the meeting. Each statement will be reviewed by Commission Members. Witnesses and members of the public are advised that in both written or oral statements presented to the Commission, they should not reveal any confidential information from any open case under investigation by an institution or the Office of Research Integrity or from any closed case where there has not been a finding of scientific misconduct or which has not otherwise been made public. Dated: September 27, 1994. Lyle W. Bivens, Director, Office of Research Integrity [FR Doc. 94&hyph;24474 Filed 10&hyph;3&hyph;94; 8:45 am] BILLING CODE 4160&hyph;17&hyph;M
